This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Ensign Up More Than 90% in a Year: Will the Rally Continue?
by Zacks Equity Research
Strong fundamentals along with industry's growth drivers are ensuring growth at Ensign (ENSG)
Has The Ensign Group (ENSG) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (ENSG) Outperforming Other Medical Stocks This Year?
The Zacks Analyst Blog Highlights: Ensign, Air China and Wal-Mart de Mexico
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Ensign, Air China and Wal-Mart de Mexico
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for FYC
Ensign Group (ENSG) Down 1.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Ensign Group (ENSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Stuck at 2800: Zacks March Market Strategy
by John Blank
Welcome to March. A relatively uninspiring period for the S&P 500 index has gotten underway. This key large-cap index is now trading in a tight range.
Arm of Ensign Group Unit Buys All County Home Care and Hospice
by Zacks Equity Research
A unit of Ensign Group's (ENSG) subsidiary buys the assets of All County Home Care and Hospice to boost its health and hospice portfolio.
Ensign Group Buys Nursing Hub to Expand in South California
by Zacks Equity Research
Ensign Group (ENSG) purchases Downey Care Center to penetrate into Southern Californian region and enrich its portfolio.
Here's Why You Should Add Ensign Group to Your Portfolio Now
by Zacks Equity Research
Banking on solid growth strategies and increasing revenues, Ensign Group (ENSG) has great potential to offer benefits to investors.
Community Health (CYH) Q4 Loss Wider Than Expected, Down Y/Y
by Zacks Equity Research
Community Health's (CYH) Q4 results disappoint with loss from decline in admissions, partially offset by lower expenses.
The Ensign Group, Inc. (ENSG) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in The Ensign Group, Inc. (ENSG).
Zacks.com featured highlights include: Ralph Lauren, Ensign, SkyWest, Cree and Est??e Lauder
by Zacks Equity Research
Zacks.com featured highlights include: Ralph Lauren, Ensign, SkyWest, Cree and Est??e Lauder
Surging Earnings Estimates Signal Upside for Ensign Group (ENSG) Stock
by Zacks Equity Research
Ensign Group (ENSG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Relative Price Strength Makes These 5 Stocks Worth Betting On
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
How Ensign Group (ENSG) Stock Stands Out in a Strong Industry
by Zacks Equity Research
Ensign Group (ENSG) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
New Strong Buy Stocks for February 11th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
Ensign Group's (ENSG) Q4 Earnings Top Estimates, Surge Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) fourth-quarter earnings rise on the back of solid segmental growth.
Ensign Group (ENSG) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 5.88% and 2.16%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Nursing Home Industry Should Thrive on Aging Population
by Zacks Equity Research
Demographic aging, growing investment and labor cost, and increasing competition will continue to shape the future of nursing home industry.
Ensign Group's (ENSG) Buyout to Expand Business in Utah
by Zacks Equity Research
Ensign Group (ENSG) acquires the real estate and operations of Bella Terra Cedar City to bolster its growth profile.
Which Stock to Emulate HCA Healthcare (HCA) Success in 2019?
by Zacks Equity Research
While HCA Healthcare (HCA) has been a runaway winner this year, other companies by virtue of strong operating fundamentals are poised for growth in 2019.
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for FYC
Welcome to the Deflation of Asset Prices
by John Blank
At the start of QE, stocks reflated. At the end, they deflated. End of story.
Welcome to the Deflation of Asset Prices
by John Blank
At the start of QE, stocks reflated. At the end, they deflated. End of story.
The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace